Filters

Cézar A Zárate-Morales, Stephen R Daniels, Michel Scemama, Anne Ourliac, Garen Manvelian, Min-Ji Charng, Albert Wiegman, Sonia Caprio, Eric Bruckert, Marie T Baccara-Dinet

Arteriosclerosis, thrombosis, and vascular biology 2022;42(12):1447-1457

Free Full Text

Abstract

New algorithms for treating homozygous familial hypercholesterolemia.

Marina Cuchel, Tycho R Tromp

Current opinion in lipidology 2022;33(6):326-335

Free Full Text

Abstract

Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study.

Jeanine Roeters van Lennep, Marcello Arca, Simone Bini, Eric Boersma, Alessia Di Costanzo, Angelo Baldassare Cefalù, Kim Steward, Laura D'Erasmo

European journal of preventive cardiology 2022;29(5):832-841

Free Full Text

Abstract

Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century.

Jacques Genest, Lindsay Hales, Isabelle Ruel, Leo E Akioyamen, Alexandre M Bélanger

European heart journal 2022;43(34):3227-3239

Full Text

Abstract

Lessons learned from the evinacumab trials in the treatment of homozygous familial hypercholesterolemia.

Etienne Khoury, Daniel Gaudet, Alex Lauzière, Laurent Croteau

Future cardiology 2022;18(6):507-518

Full Text

Abstract

How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment.

Albert Wiegman, Barbara A Hutten, Willemijn E Corpeleijn, Sibbeliene E van den Bosch

Genes 2023;14(3):669

Free Full Text

Abstract

Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.

Frederick Raal, John J P Kastelein, Anastasia Lesogor, Pierre Maheux, Zsolt Talloczy, Ran Bi, Ronen Durst

Circulation 2024;149(5):354-362

Free Full Text

Abstract

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia.

Marina Cuchel, Archna Bajaj

Journal of atherosclerosis and thrombosis 2022;29(8):1125-1135

Free Full Text

Abstract

Results: 1 – 15 / 20

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Homozygous Familial Hypercholesterolemia""[mesh_terms]

Clinical implications and outcomes of the ORION Phase III trials.

Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis.

Unveiling Familial Hypercholesterolemia-Review, Cardiovascular Complications, Lipid-Lowering Treatment and Its Efficacy.

Counseling couples at risk of having a child with homozygous familial hypercholesterolemia - Clinical experience and recommendations.

Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a systematic review and meta-analysis.

Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data.

Is Liver Transplant Curative in Homozygous Familial Hypercholesterolemia? A Review of Nine Global Cases.

Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study.

New algorithms for treating homozygous familial hypercholesterolemia.

Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study.

Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century.

Lessons learned from the evinacumab trials in the treatment of homozygous familial hypercholesterolemia.

How Genetic Variants in Children with Familial Hypercholesterolemia Not Only Guide Detection, but Also Treatment.

Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia.

Results for

""Homozygous Familial Hypercholesterolemia""[mesh_terms]